ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 95 filers reported holding ADURO BIOTECH INC in Q4 2017. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $19,000 | -17.4% | 7,778 | -21.4% | 0.00% | – |
Q2 2020 | $23,000 | -14.8% | 9,899 | -3.8% | 0.00% | – |
Q1 2020 | $27,000 | +92.9% | 10,293 | -13.3% | 0.00% | – |
Q4 2019 | $14,000 | +7.7% | 11,876 | -4.7% | 0.00% | – |
Q3 2019 | $13,000 | -40.9% | 12,461 | 0.0% | 0.00% | – |
Q2 2019 | $22,000 | -56.0% | 12,461 | 0.0% | 0.00% | – |
Q1 2019 | $50,000 | -37.5% | 12,461 | -58.9% | 0.00% | – |
Q4 2018 | $80,000 | -54.8% | 30,303 | +25.6% | 0.00% | – |
Q3 2018 | $177,000 | +4.7% | 24,119 | 0.0% | 0.00% | – |
Q2 2018 | $169,000 | -18.0% | 24,119 | +8.5% | 0.00% | – |
Q1 2018 | $206,000 | +151.2% | 22,233 | +105.3% | 0.00% | – |
Q4 2017 | $82,000 | -29.3% | 10,828 | 0.0% | 0.00% | – |
Q3 2017 | $116,000 | -1.7% | 10,828 | +4.5% | 0.00% | – |
Q2 2017 | $118,000 | +18.0% | 10,359 | +11.2% | 0.00% | – |
Q1 2017 | $100,000 | -7.4% | 9,316 | -1.5% | 0.00% | – |
Q4 2016 | $108,000 | +58.8% | 9,454 | +62.1% | 0.00% | – |
Q3 2016 | $68,000 | +7.9% | 5,834 | 0.0% | 0.00% | – |
Q2 2016 | $63,000 | – | 5,834 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |